semaglutide compound – Alliant LTC Pharmacy Addressing the Weight Loss Injectable

Injections can be given in the same area of the body, but in a different site for each dose

Interaction With SGLT2 Inhibitors SGLT2 inhibitors: * Reduce interstitial and intravascular congestion * Lower pulmonary capillary wedge pressure * Improve right ventricularpulmonary coupling They may partially offset ERArelated edema, * Hemodynamic synergy: reduced vascular stiffness alongside volume optimization * Antifibrotic and antiinflammatory effects: addressing key HFpEF drivers * Potential pulmonary benefit: relevant for HFpEF with pulmonary hypertension HF hospitalization Not yet established Mortality benefit Unknown Neutral Zibotentan has been studied primarily in pulmonary hypertension and cardiorenal disease, with HFpEFfocused outcome trials ongoing

H., Mannervik, B

& Yu, A.-M

Frequency: Deliver tesamorelin via subcutaneous injection once daily at bedtime